Curaleaf Holdings (CURLF) reported $1.3B in revenue for fiscal 2025, −5.0% year on year. That ranks #1625 by revenue among 2853 SEC filers and #150 in Healthcare. It posted a net loss of −$231M for the same year. Revenue has grown 1.5% a year on average since 2021 ($1.2B then). The fiscal 2025 balance sheet shows $2.8B in total assets, $89.2M in cash and $513M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.3B | −5.0% | FY20252025-12-31 |
| Gross profitGrossProfit | $631M | −1.5% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $25.5M | +2.9% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$231M | −$15.6M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $138M | −15.8% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $63.4M | −31.4% | FY20252025-12-31 |
| Total assetsAssets | $2.8B | −3.5% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $756M | −12.2% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $89.2M | −16.8% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $513M | +9.9% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q2 20262026-06-30 | $340M | $12.5M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 147 of 161 companies compared | −18.2% | |
| Operating marginRank 120 of 160 companies compared | 2.0% | |
| R&D as share of revenueRank 100 of 102 companies compared | 0.1% | |
| Cash as share of revenueRank 110 of 160 companies compared | 7.0% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Curaleaf Holdings, Inc.
- Ticker
- CURLF
- Exchange
- OTC
- SIC classification
- Medicinal Chemicals & Botanical Products (2833)
- Fiscal year end
- 12-31
- CIK
- 0001756770
Filings
- 10-QAug 6, 2026Open filing →
- 40-FFeb 27, 2026Open filing →
- 40-FMar 4, 2025Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| HaemoneticsHAE | $1.3B | $97,308 |
| Phibro Animal HealthPAHC | $1.3B | $48.3M |
| ProgynyPGNY | $1.3B | $58.5M |
| Curaleaf HoldingsCURLF | $1.3B | −$231M |
| Lakefront BiotherapeuticsLKFT | $1.3B | $363M |
| Indivior PharmaceuticalsINDV | $1.2B | $210M |
| Nasus PharmaNSRX | $1.2B | −$5.9M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Curaleaf Holdings — Key figures |url=https://companiesranked.com/en/company/curaleaf-holdings |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Curaleaf Holdings — Key figures. CompaniesRanked. https://companiesranked.com/en/company/curaleaf-holdingsBibTeX
@misc{companiesranked-en-company-curaleaf-holdings-2026,
author = {{CompaniesRanked}},
title = {{Curaleaf Holdings — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/curaleaf-holdings}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 40-F · 0001756770-26-000019 · February 27, 2026
{{cite web |title=Curaleaf Holdings — Key figures — 40-F (0001756770-26-000019) |url=https://www.sec.gov/Archives/edgar/data/1756770/000175677026000019/curlf-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.